Xu CH - Search Results

1

Identification of a Combined RNA Prognostic Signature in Adenocarcinoma of the Lung.

He SY, Xi WJ, Wang X, Xu CH, Cheng L, Liu SY, Meng QQ, Li B, Wang Y, Shi HB, Wang HJ, Wang ZZ. He SY, et al. Among authors: xu ch. Med Sci Monit. 2019 May 27;25:3941-3956. doi: 10.12659/MSM.913727. Med Sci Monit. 2019. PMID: 31132294 Free PMC article.

2

Identifying dysfunctional miRNA-mRNA regulatory modules by inverse activation, cofunction, and high interconnection of target genes: a case study of glioblastoma.

Xiao Y, Ping Y, Fan H, Xu C, Guan J, Zhao H, Li Y, Lv Y, Jin Y, Wang L, Li X. Xiao Y, et al. Neuro Oncol. 2013 Jul;15(7):818-28. doi: 10.1093/neuonc/not018. Epub 2013 Mar 20. Neuro Oncol. 2013. PMID: 23516263 Free PMC article.

3

Identification of cancer-related lncRNAs through integrating genome, regulome and transcriptome features.

Zhao T, Xu J, Liu L, Bai J, Xu C, Xiao Y, Li X, Zhang L. Zhao T, et al. Mol Biosyst. 2015 Jan;11(1):126-36. doi: 10.1039/c4mb00478g. Epub 2014 Oct 30. Mol Biosyst. 2015. PMID: 25354589

4

Identifying the crosstalk of dysfunctional pathways mediated by lncRNAs in breast cancer subtypes.

Wang L, Li J, Zhao H, Hu J, Ping Y, Li F, Lan Y, Xu C, Xiao Y, Li X. Wang L, et al. Mol Biosyst. 2016 Mar;12(3):711-20. doi: 10.1039/c5mb00700c. Mol Biosyst. 2016. PMID: 26725846

5

Systemically identifying and prioritizing risk lncRNAs through integration of pan-cancer phenotype associations.

Xu C, Qi R, Ping Y, Li J, Zhao H, Wang L, Du MY, Xiao Y, Li X. Xu C, et al. Oncotarget. 2017 Feb 14;8(7):12041-12051. doi: 10.18632/oncotarget.14510. Oncotarget. 2017. PMID: 28076842 Free PMC article.

6

Identification of a five-lncRNA signature for predicting the risk of tumor recurrence in patients with breast cancer.

Li J, Wang W, Xia P, Wan L, Zhang L, Yu L, Wang L, Chen X, Xiao Y, Xu C. Li J, et al. Int J Cancer. 2018 Nov 1;143(9):2150-2160. doi: 10.1002/ijc.31573. Epub 2018 Jul 28. Int J Cancer. 2018. PMID: 29707762 Free PMC article.

7

Inference of patient-specific subpathway activities reveals a functional signature associated with the prognosis of patients with breast cancer.

Han J, Liu S, Jiang Y, Xu C, Zheng B, Jiang M, Yang H, Su F, Li C, Zhang Y. Han J, et al. J Cell Mol Med. 2018 Sep;22(9):4304-4316. doi: 10.1111/jcmm.13720. Epub 2018 Jul 4. J Cell Mol Med. 2018. PMID: 29971923 Free PMC article.

8

Systematical Identification of Breast Cancer-Related Circular RNA Modules for Deciphering circRNA Functions Based on the Non-Negative Matrix Factorization Algorithm.

Wang S, Xia P, Zhang L, Yu L, Liu H, Meng Q, Liu S, Li J, Song Q, Wu J, Wang W, Yang L, Xiao Y, Xu C. Wang S, et al. Int J Mol Sci. 2019 Feb 20;20(4):919. doi: 10.3390/ijms20040919. Int J Mol Sci. 2019. PMID: 30791568 Free PMC article.

9

Dissecting the m⁶A methylation affection on afatinib resistance in non-small cell lung cancer.

Meng Q, Wang S, Zhou S, Liu H, Ma X, Zhou X, Liu H, Xu C, Jiang W. Meng Q, et al. Pharmacogenomics J. 2020 Apr;20(2):227-234. doi: 10.1038/s41397-019-0110-4. Epub 2019 Oct 17. Pharmacogenomics J. 2020. PMID: 31624334

10

Revealing the subtyping of non-small cell lung cancer based on genomic evolutionary patterns by multi-region sequencing.

Liao G, Liang X, Ping Y, Zhang Y, Liao J, Wang Y, Hou X, Jiang Z, Dong X, Xu C, Xiao Y. Liao G, et al. Cancer Med. 2020 Dec;9(24):9485-9498. doi: 10.1002/cam4.3541. Epub 2020 Oct 20. Cancer Med. 2020. PMID: 33078899 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

335 results

Search Page

Filters